Search
“egfr”
Business results
1–2 of 2-
asmointernational.com/product/gefitinib-250mg-tablets
Asmointernational
Firstly, Geftinat 250mg Tablet is used in the treatment of non-little cell breakdown in the lungs. It is used in patients in which it has spread to various bits of the body, who have atypical epidermal advancement factor receptor (EGFR) characteristics, and who have not had past treatment for the illness. Geftinat 250mg Tablet can be taken with or without food, yet better to have it at a similar time every day for better results. Therefore, The term of treatment changes as shown by your need an
-
delta.larvol.com/Institutions/4785924b1dfe4be488c3b8db47368c09/RevolutionMedicines/3/c243d78263184711975ad7db8ef4fbb6/DoseEscalationExpansion-of-RMC4630-and-Cobimetinib-in-RelapsedRefractory-Solid-Tumors-and-RMC4630-and-Osimertinib-in-EGFR-Positiv
delta.larvol.com/Institutions/4785924b1dfe4be488c3b8db47368c09/RevolutionMedicines/3/c243d78263184711975ad7db8ef4fbb6/DoseEscalationExpansion-of-RMC4630-and-Cobimetinib-in-RelapsedRefractory-Solid-Tumors-and-RMC4630-and-Osimertinib-in-EGFR-Positiv
More pages from the web
1–4 of 4-
cheapharmacy.co
cheapharmacy.co
Gefitinib is the first selective inhibitor of epidermal growth factor receptor's (EGFR) tyrosine kinase domain. Thus gefitinib is an EGFR inhibitor. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR.
-
iressa-us.com
IRESSA Access
IRESSA for advanced non-small cell lung cancer treatment with an EGFR-TK (epidermal growth factor receptor-tyrosine kinase) inhibitor. Site provides relevant lung cancer information for oncology research to health care professionals and patients
-
her2status.com
Herceptin.net - Herceptin (trastuzumab) for treatment of HER2-positive breast cancer
A resource for health care professions seeking information on Herceptin breast cancer treatment for both adjuvant and metastatic treatment settings
-
iressa.com
IRESSA (gefitinib) | Non Small Cell Lung Cancer Treatment
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy